Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page
- Check2 days agoChange DetectedLocations section updated with many new sites across the US, Canada, and other regions, and some previously listed locations were removed (Revision: v3.3.3).SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedPublication notes were updated to indicate that PubMed publications are automatically filled and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.4%

- Check37 days agoChange DetectedThe government funding/operational status notice banner was removed from the page; trial details and location information remained unchanged.SummaryDifference0.2%

- Check52 days agoChange DetectedThe updates appear to be minor formatting and text adjustments on the Study Details page, with no changes to the study design, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check87 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.